News
New research offers hope for ovarian cancer patients facing chemotherapy resistance
For many people diagnosed with ovarian cancer, chemotherapy is a standard treatment. However, despite an initial response, most patients will experience a relapse within five years, and many will develop resistance to the drugs designed to…
Colorectal Cancer: From screening to survivorship with Dr. Emil Lou and Kim Newcomer
March is Colorectal Cancer Awareness Month. This month, we had the opportunity to sit down with Dr.
Environmental Exposures on Cancer Risk and Prevention: A Conversation with Irina Stepanov, PhD
February is National Cancer Prevention Month. This month, we had the opportunity to sit down with Irina Stepanov, PhD for a discussion about the impact of environmental exposures on cancer risk and prevention. Be sure to join us…
Masonic Cancer Center announces Fall 2024 internal grant awards
The Masonic Cancer Center, University of Minnesota recently announced the awarding of $350,000 in pilot grants through its Fall 2024 Internal Grant Program. Support for these grants is made available by the center through a variety of…
Dr. Veronika Bachanova named co-leader of MCC's Transplant and Cellular Therapy research program
The Masonic Cancer Center, University of Minnesota is pleased to announce that Veronika Bachanova, MD, PhD, has been appointed as the new co-leader of MCC’s Transplant and Cellular Therapy (TCT) research program. She joins long-…
MCC and Mobile Health Initiative partner to improve community access to colorectal cancer screenings
Colorectal cancer is one of the most preventable types of cancer, but many communities face barriers to getting screened for it. In some places, people are skeptical about preventive care or are worried about cultural stigmas, which can…
New research from MCC reveals the two faces of FOXA1 mutations in prostate cancer
An exciting new study led by Dr. Justin Hwang, a researcher at the Masonic Cancer Center (MCC), University of Minnesota, and assistant professor in the U of M Medical School, has shed light on the role of FOXA1 mutations in…
Five MCC researchers inducted into 2024 UMN Academies for Excellence
Every year, the University of Minnesota works to identify its most distinguished scientists, educators, and clinicians in four key areas: clinical practice, health research, the scholarship of teaching and learning, and team science.…
Addressing barriers in cervical cancer: A conversation with Dr. Meredith Wise
This month, we had the opportunity to sit down with Meredith Wise, MD, MSCR, for an insightful conversation on barriers in cervical cancer prevention, diagnosis, and treatment. Be sure to join us for our Fireside Chat on January…
Our top 20 accomplishments of 2024
Every year, we round up a list of our top accomplishments from across the cancer center, from research, to clinical trial enrollments, to outreach and engagement, and giving. Check out our top 20 accomplishments from 2024!